SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: alias who wrote (8183)8/12/1999 9:13:00 PM
From: Xpiderman  Respond to of 9523
 
Pfizer Inc. (PFE) 34 +1: pharmaceutical company announces that it will not pursue further development of its aldose reductase inhibitor Alond for the treatment of peripheral diabetic neuropathy following recent results of a placebo-controlled study; separately, PFE in Phase III development of a novel device and formulation that delivers insulin by inhalation.....